ABUS - Arbutus Biopharma Q3 2023 Earnings Preview
2023-11-06 11:38:44 ET
More on Arbutus Biopharma
- Putting Arbutus Biopharma Back In The Spotlight
- Alnylam sends Arbutus lower after FDA snub for amyloidosis drug
- Arbutus ends development of COVID, hepatitis b candidates
- Seeking Alpha’s Quant Rating on Arbutus Biopharma
For further details see:
Arbutus Biopharma Q3 2023 Earnings Preview